Search
Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization

Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization

Author

InvestmentPitchMedia

Published on March 12, 2020

Willow Biosciences has achieved its first major commercial milestone by delivering a proprietary cannabinoid-producing yeast strain to its scale-up development partner, Albany Molecular Research, Inc. ("AMRI") to begin the process of scaling up production to commercial volumes.


Category : News

0 Comments

cmntImg
Auto Play